Sen. McCaskill Reaches Out To Retailers On Picamilon ‘In The Absence Of FDA Action’
This article was originally published in The Tan Sheet
Executive Summary
The Missouri Democrat tells retailers that FDA “hasn’t lifted a finger to inform the public or taken any action to remove” picamilon. Although an FDA official said in an affidavit to the Oregon AG that picamilon is not a dietary ingredient, the agency has not warned firms or consumers that it is unsafe.
You may also be interested in...
Supplements For Disease-Related Nutrition Shaping Consumer Health Landscape
Sales of dietary supplements promoted for nutritional needs of diabetics are exploding as consumers seek non-drug products to deal with symptoms of the disease, says a consumer health analyst in a recent presentation. Consumer health products positioned to prevent disease are growing at a much faster rate globally than those formulas that treat ailments.
GAO Memory Supplement Review Recalls FDA's Regulatory Challenges
GAO recommends better cooperation between FDA and FTC and more public outreach are key to preventing consumers from believing noncompliant cognitive benefit claims for supplements.
GOP Request To Stall New Rules: Post-Election Business As Usual On Capitol Hill
House Republican leaders' request that federal agencies halt rulemaking until Trump's inauguration was not unexpected and their request tracks with the president-elect's priority for trimming regulations. "I think it was really a move to stop the administration from trying to legislate by fiat," says NPA chief Daniel Fabricant.